首頁 > 市場調查報告書 > 製藥

疼痛

市場調查報告書

商品編碼

2008101

膝關節手術和人工關節重建疼痛管理藥物市場：按藥物、通路和地區分類

Knee Surgeries and Arthroplasty Pain Management Therapeutics Market, By Drug, By Distribution Channel, By Geography

出版日期: 2026年03月12日 | 出版商:

Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年，膝關節手術和人工關節重建術疼痛管理療法的市場規模估計為48.764億美元，預計到2033年將達到71.073億美元。預計從2026年到2033年，該市場將以5.2%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	48.764億美元
業績數據週期：	2020-2024	預測期：	2026-2033
2026-2033年預測期間的複合年成長率：	5.20%	2033年市場規模預測：	71.073億美元

有很多種藥物可用於緩解疼痛，包括鴉片類藥物、非類固醇消炎劑（NSAIDs）和乙醯胺酚。這些藥物可以提高患者的舒適度，使其能夠更早恢復活動，更快地從體力消耗中恢復，並加速膝關節手術或人工關節重建的康復。

此外，預計在預測期內，全膝關節置換術的數量將會增加，從而推動市場成長。

例如，根據美國國家生物技術資訊中心 (NCBI) 2017 年公佈的數據，巴西每年進行的全膝關節置換術估計數量在 6 萬至 7 萬例之間。

市場動態

預計在預測期內，主要企業活性化研發力度，致力於開發和推出用於膝關節手術和人工關節重建的疼痛管理療法，這將推動全球用於膝關節手術和人工關節重建的疼痛管理療法市場成長。

例如，2021年5月，Alley Therapeutics——一家致力於研發超長效鎮痛藥的臨床階段生物技術公司，旨在革新術後疼痛管理和康復——公佈了首個臨床數據，證明其非鴉片類鎮痛藥單次給藥後即永續兩週。現有術後鎮痛藥物的療效通常只能維持三天。此數據來自Alley公司首個候選藥物ATX-101的1b/2a期臨床試驗，該藥物用於治療全膝關節關節重建（TKA）後的疼痛。

此外，藥品核准的增加預計也將促進市場成長。例如，2020年3月，GlaxoSmithKline Plc宣布，美國食品藥物管理局（FDA）已核准「Advil Dual Action（含對乙醯胺酚）」作為非處方止痛藥上市。「Advil Dual Action」是一種領先的配方，結合了對乙醯胺酚和Ibuprofen這兩種強效成分，它們均已獲準用於非處方藥，能夠有效緩解多種症狀，並透過不同的作用機制發揮作用。

本次調查的主要特點。

本報告以 2025 年為基準年，對全球膝關節手術和人工關節重建疼痛管理療法市場進行了詳細分析，並預測了其在預測期（2026-2033 年）內的複合年成長率（%）。
本報告指出了各個細分市場的潛在商機，並說明了該市場中具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業所採取的競爭策略的關鍵見解。
本報告根據以下參數分析了全球膝關節手術和人工關節重建疼痛管理療法市場的主要企業：公司概況、產品系列、主要亮點、財務表現和策略。
透過利用本報告中提出的見解，企業行銷負責人和經營團隊可以就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
本報告面向該產業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過各種策略矩陣，相關人員將能夠更輕鬆地做出決策，這些矩陣用於分析膝關節手術和人工關節重建疼痛管理療法的全球市場。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太地區
中東
- GCC
- 以色列
- 其他中東國家
非洲
南非
中非
北非

第7章競爭情勢

衝突簡介
- Pfizer Inc
- Allay Therapeutics
- Mallinckrodt
- Johnson &Johnson
- Zydus Cadila Healthcare Ltd.
- Novartis AG
- Purdue Pharma
- Delphis Pharmaceutical
- Taj Pharmaceuticals Limited
- GlaxoSmithKline plc
- AbbVie Inc
- Aurobindo Pharma

第8章

參考
調查方法

簡介目錄

Product Code: CMI4998

Knee Surgeries And Arthroplasty Pain Management Therapeutics Market is estimated to be valued at USD 4,876.4 Mn in 2026 and is expected to reach USD 7,107.3 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.2% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 4,876.4 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.20%	2033 Value Projection:	USD 7,107.3 Mn

Many types of medicines are available to help control pain, including opioids, non-steroidal anti-inflammatory drugs (NSAIDs), Acetaminophen, etc. Medications help people feel more comfortable, allowing one to start moving sooner, get the strength back more quickly, and recover from knee surgeries and arthroplasty faster.

Furthermore, increasing number of total knee arthroplasty is expected to drive the market growth over the forecast period

For instance, according to data published by National Center for Biotechnology Information in 2017, the number of total knee arthroplasty is estimated to range between 60,000 and 70,000 per year in Brazil.

Market Dynamics

Increasing research and development activities by the key players for the development and launch of knee surgeries and arthroplasty pain management drugs are expected to drive the growth of the global knee surgeries and arthroplasty pain management therapeutics market over the forecast period.

For instance, in May 2021, Allay Therapeutics, a clinical-stage biotechnology company, pioneering ultra-sustained analgesic products to transform post-surgical pain management and recuperation, announced the first-ever clinical data showing non-opioid pain relief lasting two weeks after a single administration. The existing post-surgical pain products have shown effectiveness for a maximum of three days after a single dose. The data come from a Phase 1b/2a clinical study of Allay's first candidate, ATX-101, in development to treat pain after total knee arthroplasty (replacement) or TKA surgery.

Moreover, increasing approval of drug is also expected to boost the market growth. For instance, in march 2020, GlaxoSmithKline Plc. announced that the U.S. Food and Drug Administration had approved Advil Dual Action with Acetaminophen, as an (OTC) over-the-counter product for pain relief. Advil Dual Action gives relief for various symptoms and is the major formulation that merges acetaminophen and ibuprofen, 2 strong ingredients indicated for over-the-counter pain relief that work in different ways.

Key features of the study

This report provides an in-depth analysis of the global knee surgeries and arthroplasty pain management therapeutics market, market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global knee surgeries and arthroplasty pain management therapeutics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer Inc, Allay Therapeutics, Mallinckrodt, Johnson & Johnson, Zydus Cadila Healthcare Ltd., Novartis AG, Purdue Pharma, Delphis Pharmaceutical, Taj Pharmaceuticals Limited, GlaxoSmithKline plc, AbbVie Inc., and Aurobindo Pharma
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global knee surgeries and arthroplasty pain management therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global knee surgeries and arthroplasty pain management therapeutics market

Market Segmentation

By Drug
- Acetaminophen
- COX-2 inhibitors
- Opioids
- Non-steroidal Anti-inflammatories
- Ketamine
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Pfizer Inc
- Allay Therapeutics
- Mallinckrodt
- Johnson & Johnson
- Zydus Cadila Healthcare Ltd.
- Novartis AG
- Purdue Pharma
- Delphis Pharmaceutical
- Taj Pharmaceuticals Limited
- GlaxoSmithKline plc
- AbbVie Inc.
- Aurobindo Pharma

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Drivers
Restraints
Opportunity
Impact Analysis
Number of Total Knee Arthroplasty Surgeries
Key Developments
Regulatory Scenario
PEST Analysis
Pipeline Analysis
Overview of Postoperative Pain Management Regimes for Total Knee Arthroplasty

4. Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market, By Drug, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Acetaminophen
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
COX-2 inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Opioids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Non-steroidal Anti-inflammatories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Ketamine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market, By Distribution Channel, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Knee Surgeries and Arthroplasty Pain Management Therapeutics Market, By Region, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2033
North America
- Market Size and Forecast, By Drug, 2021-2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
  - U.S.
  - Canada
Latin America
- Market Size and Forecast, By Drug, 2021-2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Market Size and Forecast, By Drug, 2021-2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Drug, 2021-2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Drug, 2021-2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Mn)
- Market Size and Forecast, By Country, 2021-2033, (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Drug, 2021-2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Mn)
- Market Size and Forecast, By Region/Country, 2021-2033, (USD Mn)
South Africa
Central Africa
North Africa